PharmaShots Weekly Snapshots (June 20 – 24, 2022)
Sanofi and GSK Report Results of COVID-19 Vaccine in the P-III (VAT08) Trial Against Omicron
Published: June 24, 2022 | Tags: Sanofi, GSK, COVID-19 Vaccine, Omicron, Clinical Trial, P-III, VAT08 Trial
Argenx Receives CHMP Positive Opinion of Efgartigimod as an Add-on to Standard Therapy for Generalized Myasthenia Gravis
Published: June 24, 2022 | Tags: argenx, CHMP, Efgartigimod, Generalized Myasthenia Gravis
Published: June 24, 2022 | Tags: AstraZeneca, Enhertu, HER2-Positive, Metastatic Breast Cancer, Health Canada, Approval
Published: June 24, 2022 | Tags: Astellas, Fezolinetant, Vasomotor Symptoms, Menopause, Regulatory, NDA, US, FDA
Published: June 24, 2022 | Tags: Gilead, Hepcludex, bulevirtide,, Chronic Hepatitis Delta Virus, P-III MYR301 Trial, ILC, 2022
invoX Pharma to Acquire F-star Therapeutics for ~$161M
Published: June 24, 2022 | Tags: invoX Pharma, F-star Therapeutics, Cancers, M&A, Acquire, ~$161M, Tetravalent (2+2) Bispecific Ab Platform
Published: June 23, 2022 | Tags: uniQure, AMT-130, Huntington’s Disease, Clinical Trials, Low-Dose Cohort, P-I/II Clinical Trial
Published: June 23, 2022 | Tags: Apellis, Affilogic, Nanofitins-Based Therapies, Neurological Diseases , Pharma, APL-1030, APL-2006
Published: June 23, 2022 | Tags: Zynerba, Zygel, with 22q11.2 Deletion Syndrome, Clinical Trials, P-II INSPIRE Trial
Published: June 23, 2022 | Tags: BridgeBio, BBP-812, Canavan Disease, Clinical Trial, P-I/II, CANaspire Trial
Published: June 23, 2022 | Tags: Aveo, Eli Lilly, Ficlatuzumab, Erbitux, cetuximab, HNSCC, Pharma, North America
Published: June 23, 2022 | Tags: Pasithea Therapeutics, Alpha-5 Integrin, ALS, Neurological, M&A, ~$3.75M
Published: June 23, 2022 | Tags: Merck, Vaxneuvance, pneumococcal 15-valent conjugate vaccine, Invasive Pneumococcal Disease, US, FDA, Approval
Published: June 22, 2022 | Tags: Galderma, Nemolizumab, P-III, OLYMPIA 2 Trial, Prurigo Nodularis
Inivata and Collaborators Report Results of RaDaR MRD Test in (CHiRP) Study for the Treatment of Breast Cancer
Published: June 22, 2022 | Tags: Inivata, RaDaR MRD Test, CHiRP Study, Breast Cancer
Published: June 22, 2022 | Tags: Acer Therapeutics, Relief, US, FDA, CRL, ACER-001, NDA, Urea Cycle Disorders
Galapagos to Acquire CellPoint and AboundBio to Advance Cell Therapies for the Treatment of Advanced Cancer
Published: June 22, 2022 | Tags: Galapagos, Acquire, CellPoint, AboundBio, Cell Therapies, Advanced Cancer
Published: June 22, 2022 | Tags: Precision BioSciences, In Vivo, Gene Editing, Novartis, Sickle Cell Disease, Beta Thalassemia
Published: June 21, 2022 | Tags: Ionis, Eplontersen, P-III, NEURO-TTRansform Study, Hereditary, Transthyretin-Mediated, Amyloid Polyneuropathy
Published: June 21, 2022 | Tags: EC, Antitrust Investigation, Vifor Pharma, Anti-Competitive Disparagement, Iron Deficiency
Oxford BioDynamics Launches EpiSwitch CiRT Blood Test for the Treatment of Cancer in the UK
Published: June 21, 2022 | Tags: Oxford BioDynamics, EpiSwitch CiRT Blood Test, Cancer, UK
Published: June 21, 2022 | Tags: Edgewise Therapeutics, EDG-5506, Becker Muscular Dystrophy, P-Ib, ARCH Study
Published: June 21, 2022 | Tags: Pfizer-BioNTech, COVID-19 Vaccine, US, FDA, EUA, COVID-19
Published: June 21, 2022 | Tags: Innovent, Lilly, Tyvyt, sintilimab, Esophageal Squamous Cell Carcinoma, NMPA, Approval
Published: June 20, 2022 | Tags: Novartis, Zolgensma, Spinal Muscular Atrophy, P-III, SPR1NT Trial, Nature Medicine
Published: June 20, 2022 | Tags: BMS, Breyanzi, lisocabtagene maraleucel, Large B-cell Lymphoma , EMA, Type II Variation Application
Published: June 20, 2022 | Tags: Myovant, Pfizer, Relugolix Combination Therapy, Endometriosis, Pain, P-III, SPIRIT 1 & 2 Studies
Published: June 20, 2022 | Tags: AbbVie, Skyrizi, risankizumab-rzaa, Crohn's Disease, US, FDA, Approval
Zura Bio to Go Public via JATT SPAC Merger for ~$215M
Published: June 20, 2022 | Tags: Zura Bio, Public, JATT, SPAC Merger, ~$215M, ZB-168
Published: June 20, 2022 | Tags: ObsEva, Yselty, linzagolix, EC, Marketing Authorization, Uterine Fibroids
Related Post: PharmaShots Weekly Snapshots (June 13– 17, 2022)
Tags
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.